Skip to main content
. 2023 Mar 30;18(1):2196759. doi: 10.1080/15592294.2023.2196759

Table 1.

Study participant characteristics.

Variable Study Population
Sample time point 1 (n = 68) Sample time point 2 (n = 75)
Age, years   50.0 (40.1–50.2) 60.0 (50.5–60.1)
Body mass index, kg/m^2   25.7 (23.6–27.4) 26.5 (24.4–28.4)
Body mass index groups, n (%) Underweight (<18.5) 0 (0.0) 0 (0.0)
  Normal weight (18.5–24.9) 26 (38.2) 23 (31.1)
  Overweight (25.0–29.9) 36 (53.0) 38 (51.3)
  Obese (>30.0) 6 (8.8) 12 (16.2)
  Unknown 0 (0.0) 1 (1.4)
Smoking status, n (%) Never 29 (42.6) 36 (48.7)
  Former 18 (26.5) 24 (32.4)
  Current 18 (26.5) 10 (13.5)
  Unknown 3 (4.4) 4 (5.4)
Alcohol consumption, grams/day   4.4 (2.2–7.6) 5.4 (2.3–7.9)
Serological levels Androstenedione, ng/mL 0.9 (0.7–1.2) 0.7 (0.5–0.9)
  Dehydroepiandrosterone, ng/mL 3.6 (2.9–5.0) 2.4 (1.5–3.1)
  Estrone, pg/mL 31.9 (25.1–35.5) 30.0 (25.4–37.6)
  Estradiol, pg/mL 17.6 (15.7–22.6) 17.6 (15.3–22.1)
  Progesterone, pg/mL 57.9 (40.2–84.3) 47.7 (32.8–70.5)
  Testosterone, ng/mL 3.7 (3.1–4.1) 3.1 (2.7–3.7)
  Free estradiol, pg/mL 0.5 (0.4–0.7) 0.5 (0.4–0.6)
  Free testosterone, pg/mL 75.3 (66.5–85.4) 64.8 (53.7–70.8)
  SHBG, nmol/L 25.1 (19.1–33.3) 25.56 (19.6–36.0)